A

Allianz Research Institute | Westminster, CA

Research site
(Unclaimed)
Location
14120 Beach Boulevard 101, Westminster, California, United States of America
Site insights

Top conditions

Obstructive Lung Diseases (3 trials)

Chronic Obstructive Pulmonary Disease (3 trials)

Lung Diseases (3 trials)

Asthma (2 trials)

Cardiovascular Diseases (2 trials)

Top treatments

Astegolimab
Bococizumab
EDP-938
Dupilumab
RPT193
BPS-314d-MR-PAH-303
VIR-7831

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

5 of 12
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

ACT18018 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 2 study with 3 treatment groups. The purpose of this...

Enrolling
Bronchiectasis
Drug: Placebo
Drug: Itepekimab (SAR440340)

This is a Phase 2b, randomized, double-blind, placebo-controlled study of EDP-938 administered orally for the treatment of non-hospitalized adult sub...

Enrolling
RSV Infection
Drug: EDP-938
Drug: Placebo

This study will evaluate the efficacy, safety, and pharmacokinetics of astegolimab in combination with standard of care chronic obstructive pulmonary...

Enrolling
Chronic Obstructive Pulmonary Disease
Drug: Astegolimab
Drug: Placebo

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmo...

Enrolling
Chronic Obstructive Pulmonary Disease
Drug: Astegolimab

Primary Objective:To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate or severe Chronic Obstructive Pulmonary...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Inhaled Long-Acting Muscarinic Antagonist

Trial sponsors

Enanta Pharmaceuticals logo

Enanta Pharmaceuticals (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems